Ronald Todd Plott
Ronald Todd Plott has made 1 open-market purchase worth $10k since Sep 30, 2026, in 1 company. The latest: $10k of PHIO, filed Sep 30, 2026, scored 30 out of 100.
Director, Phio Pharmaceuticals Corp.
Follow Ronald Todd Plott, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Sep 30 Form 4 (opens sec.gov) |
PHIOPhio Pharmaceuticals Corp. · DirectorDirector · Near 52-week low · Penny stock: hard to trade | +31% stake | 30 | $10k 10,000 at $1.03 |
— | — |
Questions
What stock has Ronald Todd Plott bought?
PHIO (Phio Pharmaceuticals Corp.), all on the open market and reported on SEC Form 4.
When did Ronald Todd Plott last buy?
Sep 30, 2026: 10,000 shares of PHIO at $1.03, $10k in all (Form 4 (opens sec.gov)).
Has Ronald Todd Plott filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Ronald Todd Plott a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Sep 30, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer